Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × rucaparib × 1 year × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of the Oesophagus 1 Adenocarcinoma of Lung 1 ATM Gene Mutation 1

Interventions

Gemcitabine 48 pembrolizumab 40 Cisplatin 37 Magnetic Resonance Spectroscopy 23 Specimen Handling 21 Cystectomy 19 Nivolumab 18 enfortumab vedotin 15 durvalumab 15 Carboplatin 14 atezolizumab 13 avelumab 12 Docetaxel 12 Cystoscopy 12 Mitomycin 10 Radiation 8 Paclitaxel 8 Ipilimumab 8 Fluorouracil 8 sacituzumab govitecan 7 Radiotherapy 7 Transurethral Resection of Bladder 6 Standard of Care 6 Platinum 6 Immunoglobulin G 6 Disulfides 6 1,2-diaminocyclohexaneplatinum II citrate 6 erdafitinib 5 cemiplimab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡